Join
Live feed
·
INSIDERFilingvia Quantisnow
Fennec Pharmaceuticals Inc. logo

Chief Medical Officer Sayad Pierre Sargis converted options into 168 shares, increasing direct ownership by 0.81% to 20,847 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FENC· Fennec Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FENC (Fennec Pharmaceuticals Inc.) and more on Quantisnow.